...
首页> 外文期刊>Frontiers in Neurology >Pathogenic microRNAs Common to Brain and Retinal Degeneration; Recent Observations in Alzheimer’s Disease and Age-Related Macular Degeneration
【24h】

Pathogenic microRNAs Common to Brain and Retinal Degeneration; Recent Observations in Alzheimer’s Disease and Age-Related Macular Degeneration

机译:脑和视网膜变性常见的致病性microRNA;阿尔茨海默氏病和与年​​龄有关的黄斑变性的最新观察

获取原文
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs (miRNAs), ~22?nt single-stranded non-coding RNAs (ncRNAs) abundant in the human brain and retina, have emerged as significant post-transcriptional regulators of messenger RNA (mRNA) abundance and complexity in the human central nervous system (CNS) in aging, health, and disease. Of the 2050 different miRNAs in the human body so far identified, only about 25–30 are abundant in either the brain or the retina, underscoring the high selection pressure carried by RNA sequences located within these select ncRNAs ( 1 – 7 ). It is noteworthy to point out that: (i) that brain neocortex and retina share a common neuroectodermal origin; (ii) that brain and retina share a subfamily of specific miRNA species; and (iii) that the multilayered assemblies of both neural and retinal cells are targeted by pathogenic processes that drive progressive pro-inflammatory neurodegeneration ( 5 – 9 ). Indeed, pathologically up-regulated miRNAs common to both the prototypic age-related inflammatory degeneration of the brain in Alzheimer’s disease (AD) and of the retina in age-related macular degeneration (AMD) appear to be associated with deficits in the expression of messenger RNA (mRNA) and gene families involved in the innate-immune response, inflammation, neurotrophism, synaptogenesis, and amyloidogenesis (Figure 1 ). In this “Opinion” paper for the Frontiers in Neurology Special Research Topic , we will highlight some of the most recent work in this research area, with emphasis on a family of five up-regulated pro-inflammatory miRNAs?–?miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, and miRNA-155?–?that are emerging as key mechanistic contributors to the AD and AMD process. Figure 1 (A) Color-coded cluster analysis of significantly up-regulated microRNAs (miRNAs) in the neocortex of AD ( N ?=?5) versus age-matched controls ( N ?=?5) and (B) in the whole retina of AMD ( N ?=?5) versus age-matched controls ( N ?=?5); this small family of “pro-inflammatory” miRNAs consisting of miRNA-9, miRNA-34a, miRNA-125b, miRNA-146a, and miRNA-155 are often found to be up-regulated approximately twofold or more over controls (small red arrows); interestingly these miRNAs are inducible and under transcriptional control by NF-kB [Figure 1 adapted from Ref. ( 10 – 13 )]; the relative expression levels for two sequence-related microRNAs, miRNA-146a and miRNA-155 the brain neocortex and retina are shown in (C) relative to levels for an unchanging brain and retinal control miRNA-183, which was set to 1.0 and marked by a dashed horizontal line; another abundant control signal is 5SRNA with a relative signal strength of ~5.0 (shown at ~1/20th of its actual abundance in the brain and retina; see text) ( 12 , 13 ). In these samples, all control and AD neocortical samples were obtained from the superior temporal neocortex (Brodmann area A22); control and AMD retinal samples were obtained from whole retina; all control, AD and AMD samples had post-mortem intervals (PMI; death to brain freezing interval) of 2?h or less ( 2 , 9 , 10 ). Controls were age-matched to moderate-to-late stages of AD or AMD; increases in specific miRNAs increased as disease stage advanced [Ref. ( 11 , 12 , 14 – 17 ); data not shown]; further details on the pathology of these samples have been recently published ( 11 – 20 ). There were no significant differences in age, PMI, or RNA yield or quality between either the brain or the retinal tissues. Of the 12 different homo sapien micro-RNAs (hsa-miRNAs) shown, miRNA-146a and miRNA-155 exhibited the most consistent up-regulation compared with age-matched controls (* p ?
机译:MicroRNA(miRNA)是在人脑和视网膜中丰富的〜22nt单链非编码RNA(ncRNA),已成为人类中枢神经系统中信使RNA(mRNA)丰度和复杂性的重要转录后调节剂。 (CNS)在衰老,健康和疾病中的表现。迄今为止,在人体中发现的2050种不同的miRNA中,大脑或视网膜中只有约25–30种丰富的miRNA,这突显了位于这些ncRNA内的RNA序列所承受的高选择压力(1 – 7)。值得指出的是:(i)脑新皮层和视网膜具有共同的神经外胚层起源; (ii)大脑和视网膜共享特定miRNA物种的亚家族; (iii)神经和视网膜细胞的多层组装体是由引起进行性促炎性神经退行性变的致病过程所靶向的(5 – 9)。实际上,阿尔茨海默氏病(AD)和年龄相关性黄斑变性(AMD)的原型与年龄相关的大脑炎症性变性和视网膜相关的病理上调的miRNA似乎与信使表达不足有关RNA(mRNA)和基因家族参与先天免疫应答,炎症,神经营养,突触形成和淀粉样蛋白生成(图1)。在针对神经病学前沿特别研究主题的“意见”论文中,我们将重点介绍该研究领域的一些最新工作,重点是五个上调的促炎性miRNA?–miRNA-9家族, miRNA-34a,miRNA-125b,miRNA-146a和miRNA-155?-逐渐成为AD和AMD过程的主要机制。图1(A)与整个年龄匹配的对照(N == 5)和(B)相比,AD新皮层(N == 5)中显着上调的microRNA(miRNA)的颜色编码聚类分析AMD的视网膜(N = 5)与年龄匹配的对照组(N = 5);通常,发现这个由miRNA-9,miRNA-34a,miRNA-125b,miRNA-146a和miRNA-155组成的“促炎性” miRNA小家族的表达量比对照高约两倍或更多(红色小箭头);有趣的是,这些miRNA是可诱导的,并受NF-kB的转录控制[图1改编自参考文献。 (10 – 13)]; (C)中显示了两个与序列相关的microRNA,即大脑新皮层和视网膜的miRNA-146a和miRNA-155的相对表达水平,相对于不变的大脑和视网膜对照miRNA-183的水平,将其设置为1.0并标记为用水平虚线表示;另一个丰富的控制信号是5SRNA,相对信号强度为〜5.0(显示为大脑和视网膜中其实际丰度的〜1/20处;参见文本)(12,13)。在这些样品中,所有对照和AD新皮层样品均从颞上皮层(Brodmann区域A22)获得。从整个视网膜获得对照和AMD视网膜样品;所有对照,AD和AMD样品的死后间隔(PMI;死亡至脑冻结间隔)均小于或等于2小时(2、9、10)。对照组的患者年龄匹配至中晚期至AD或AMD。随着疾病阶段的进展,特定miRNA的表达增加[Ref。 (11,12,14-17);数据未显示];这些样品的病理学的更多详细信息已于最近发表(11 – 20)。在大脑或视网膜组织之间,年龄,PMI或RNA产量或质量均无显着差异。在显示的12种不同的智人微RNA(hsa-miRNA)中,与年龄匹配的对照组相比,miRNA-146a和miRNA-155表现出最一致的上调(* p 0.05; ** p 0.05 0.01,方差分析); (D)补体因子H(CFH)的mRNA的3'UTR;先天免疫和炎症反应的主要调节剂,见正文; [(21,22)]是多种常见miRNA?–?miRNA-146a和miRNA-155对大脑和视网膜基因表达调控的主要例子; (D)显示了miRNA-146a或miRNA-155与232nt CFH 3'UTR序列的一部分之间的互补图。 CFH mRNA 3'UTR中的miRNA-146a和miRNA-155高亲和力结合位点重叠(每个缔合能小于?22?kcal / mol),这定义了异常稳定的miRNA-mRNA相互作用,并且可能是常见的CFH mRNA 3'-UTR miRNA调节控制区域5'-TTTAGTATTAA-3'(绿色;参见文本)(12,13,23);我们不能排除其他人类大脑或视网膜富集的miRNA或其他小型ncRNA的参与,它们可能另外有助于AD或AMD病理的神经病理机制; (E)结合起来,这些最新发现在一定程度上定义了患病的大脑和视网膜中NF-kB敏感,上调的miRNA的高度互动网络,这可以解释与AD和AMD相关的许多病理观察。中枢神经系统丰富的miRNA-125b是这个上调的miRNA组的核心成员,可能部分负责驱动吞噬作用的缺陷(在小胶质细胞中表达的触发受体

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号